Eterna Therapeutics (ERNA) 10-Q2009 Q2 Quarterly report

Filed: 14 Aug 09, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: accredited, aforementioned, alter, assigned, assimilating, attention, authoritative, breadth, Bulletin, Codification, CodificationTM, creditor, deviate, distracted, diversion, doubtful, DSL, encountered, EVP, exceeded, expend, factor, human, incurrence, line, owner, partially, preliminary, promulgated, pronouncement, properly, recovery, resignation, return, single, straight, suffer, supply, tangible, team, technical, thereunder, unanticipated, unknown, unpatented

Removed: amusement, Attorney, calling, Code, constitute, copied, disposing, evaluating, free, furnish, furnished, greatest, internet, maintain, objected, opportunity, payable, practicable, President, promote, proxy, purpose, remained, restricted, Room, Street, taxable, unique, vehicle

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

ERNA similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

Certification pursuant to Rule 13a-14(b) / Section 1350

In connection with the Quarterly Report of NTN Buzztime, Inc. (the “Registrant”) on Form 10-Q for the period ended June 30, 2009, I, Kendra Berger, Chief Financial Officer, do hereby certify that:

(1)	the Quarterly Report on Form 10-Q of the Registrant for the period ended June 30, 2009, as filed with the Securities and Exchange Commission (the “Report”), fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Registrant.


Dated: August 14, 2009	/s/ KENDRA BERGER
	Kendra Berger
	Chief Financial Officer
	NTN Buzztime, Inc.